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ABSTRACT 
Vyanga is the one of the Kshudra Roga, characterised by Niruja (painless), Shyava Varna Mandalas 
(bluish black patches) occurring especially on the face. While considering the pathogenesis of 
Vyanga, involvement of Pitta is more and it is Rakta Pradoshaja vyadhi. On the basis of clinical 
features it is correlated with melasma, or facial melanosis, one of the hyper pigmented disorders. 
Melasma is a common acquired hypermelanosis that affects sun- exposed areas of skin. This study 
is important since melasma is a disease causing mental side effects in patients, due to darkness 
and opacity of the skin; therefore, the treatment of melasma in terms of its psychological 
complication is of particular importance. Jatiphala (Myristica fragrans Houtt.) is an important 
drug which has got various medicinal uses. The seed and aril of Jatiphala (Myristica fragrans 
Houtt.) of family myristicaceae have the utilized therapeutically as medicine as well as a spice. 
Acharya Bhavamishra have mentioned Jatiphala (Myristica fragrans Houtt.) as a single herbal 
remedy for its action on Vyanga.  
Intervention and duration: 30 patients having hyperpigmentation on face with clinical 
manifestations, fulfilling the diagnostic criteria of Vyanga, the prepared Lepa churna was applied 
over the affected area, once a day for 60 days. Pre test assessment was done on 15th day, 30th and 
60thday. Results: The subjective and objective parameters of the study were graded and the 
results of the study were analysed statistically using descriptive statistics where the study has 
shown statistically significant in the subjective and objective parameters. Conclusion: This 
clinical study of Jatiphala churna lepa showed the result in 50-60% of people in the group of 
Vyanga. 
KEYWORDS: Jatiphala, Vyanga, Melasma, Jatiphalachoorna lepa. 
INTRODUCTION 
 ‘Face is the index of mind’. The clean and 
clear face plays important role in the individual’s 
personal, emotional, and social well-being. Acquired 
hyperpigmentation disorders of the skin are among 
the most common complaint in a general 
dermatology clinic[1]. Melasma is a common 
pigmentary disorder. It is a form of acquired 
hypermelanosis and occurs in sun exposed parts. It 
develops mostly on the face but occasionally it can 
also develop on the neck. Rarely, it can also appear 
on the forearms as well. Melasma is resistant to 
treatment and often causes significant psychological 
impact on the patient. It affects both males and 
females but predominantly seen in females[2]. 
Hyperpigmentation (melanosis) is a group of 
disorders characterized by abnormally darker skin 
that results from increase in the concentration of 
pigment, which occurs either due to increase the 
number of melanocytes or increase activity of 
melanocytes[3]. Melanosis most commonly results 
from exposure to sunlight, due to air pollution, 
different cosmetic using habits, stressful life, dietary 
changes, inclination towards junk or fast food3. 
Nowadays Vyanga becomes one of the biggest 
problems of the society. Many people are suffering 
from Vyanga today. Among them women are 
commonly found due to changes occurring during 
pregnancy and use of cosmetic supplements[4]. 
In Ayurveda skin diseases are included under 
the heading of Kustha and Kshudra roga[4]. Acharya 
Sushrutha was the first person who has given a detail 
and separate description of the disease Vyanga in the 
chapter of ‘Kshudra Roga’. Vyanga is a pathological 
situation of the facial skin which is produced due to 
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the vitiation of Vata, Pitta and Rakta producing 
cardinal features such as Niruja, Tanu, Shyava 
Mandala [5]. 
In the context of Vyanga both Shodana and 
Shamana Chikitsa are explained in the form of 
Raktamokshana, Lepa, Abhyanga, and oral 
medication[6]. As the disease has local spread over 
the skin of the face, the local or external applications 
have immediate impact upon the characteristics 
features of the Vyanga, such as discoloration, dryness 
on the face, burning sensations, itching etc. 
Alepa being mentioned under 
Bahyaupachaara and for correcting Bhrajakapitta 
located in the skin, absorbs the drug into the body 
through skin[7]. 
Acharya charaka has broadly classified 
chikitsa under three main headings, namely Antah 
Patimarjana, Bahir Parimarjana, and Shastra 
Prranidhana. Lepa kalpana is the Upakalpana, which 
comes under Bahir Parimarjana Chikitsa[8]. 
The Lepa which is applied on the face gives 
strength to the muscle of eyes, cheeks has to be thick 
which enhance face complexion which in turns cures 
Vyanga. Alepa normalizes Rakta and Pitta[9]. 
So, the Lepa which is one of the forms of 
external application for skin diseases is taken for this 
study. 
Jatiphaladi Choorna Lepa is a formulation 
mentioned in Bhavaprakasha. Jatiphala (Myristica 
fragrans Houtt.) it has properties like Katu Tikta 
Rasa, Laghu Tikshna Guna, Ushna Virya, Katu Vipaka, 
Vatakapha hara, Varnya, Dipana, Grahi in action. 
Classics say that the fine powder of these drug, made 
into paste using water and applied over the Mukha 
Pradesha, relieves Vyanga[10]. 
In Jatiphala myristicin present, is known to be 
useful in reducing the production of melanin 
secretion in skin. It also has antioxidant properties 
which act on free radicals. It was also observed that 
Jatiphala have got exfoliating property, which help in 
formation of new fresh healthy skin removing 
unhealthy layer[11]. 
Hence the present study was undertaken to 
evaluate the efficacy of Jatiphaladi choorna Lepa in 
the management of Vyanga with special reference to 
melasma on face with the hope of quicker action.  
MATERIALS AND METHODS 
Phase 1: Collection and preparation of Jatiphala 
churna 
Phase 2: Clinical studies. 
Source of Data 
Literary source: The literary data was collected 
from classical Ayurvedic texts, modern text books, 
Samhitas, Nighantus, websites, articles and various 
journals. 
Source of drugs: Botanically identified drug of 
Jatiphala (Myristica fragrans Houtt.) was collected 
from its natural habitat. The test drug was prepared 
from Rasa Shastra & Bhaishajya kalpana department 
Rasashala of Ramakrishna Ayurvedic Medical 
College, Yelahanka, Bangalore.  
Source of patients: patients who attended OPD of 
RAMC hospital, medical camps and other referrals 
with the compliance of macular brownish/blackish 
discolouration over the face, nose, forehead, upper 
lip with the diagnosis of Vyanga or melasma were 
selected fulfilling the inclusion and exclusion criteria. 
Selection of patients 
Patients suffering from signs and symptoms 
of Vyanga roga were selected from OPD of RAMCH, 
Bengaluru, Medical camps, and other reference 
irrespective of their sex, religion, occupation etc. 
Detailed history was taken and a special research 
proforma was prepared for the study incorporating 
all the relevant points from both Ayurvedic and 
Modern views. 
Study design 
It is an open label single arm clinical study. 
30 patients will be selected from random sampling 
procedure. 
Sample size: A total of 30 patients were studied. 
Dosage: Quantity sufficient 
Plan of treatment 
Patients were apply the paste of Jatiphala 
churna with water over affected area for 60 days 
with the thickness of ½ Angula once in a day. 
Duration: The duration of the study was 60 days. 
Follow up: Follow up was done at an interval of 15 
days up to 2months. 
Inclusion criteria 
 Patients from the age group 26-60. (of either 
gender, religion, occupation, socio- economic 
status). 
 Patient representing signs and symptoms of 
Hypermelanosis (Vyanga) who were willing to 
participate in study. 
Exclusion criteria 
 Patients having systemic and endocrinal 
diseases, like Addison’s diseases, Cushing’s 
syndrome etc. 
 Hyperpigmentation since birth. 
 Hyperpigmentation caused by tumor like 
malignant melanoma. 
 Patients with drug induced chloasma. 
 Patients who were not willing to participate. 
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Ethical consideration 
Ethical clearance was obtained from the 
institutional ethical committee of Ramakrishna 
Ayurvedic Medical College and Hospital, Yelahanka, 
Bengaluru. 
Criteria of withdrawal 
 Increase symptoms like redness of the skin, 
Kandu (itching), and excessive burning sensation. 
 Patients who are not willing to continue. 
Diagnostic criteria 
Patients are diagnosed as per clinical features 
mentioned in classics. 
1. Niruja – painless patches. 
2. Tanu – light brown pigmentation on facial skin. 
3. Shyava – dark brown pigmentation on facial 
skin. 
4. Mukhamaagatya mandala – patches over face. 
Assessment criteria 
The subjective and objective parameter of 
baseline data to pre and post medication was 
compared for assessment of the results. 
Subjective parameter 
The signs and symptoms of Vyanga as well as 
Hypermelanosis explained in Ayurvedic and Modern 
texts will be subjective parameters. 
1. Neerujam (painless lesion) 
2. Shyavam (brownish pigmentation) 
3. Tanu (light pigmentation) 
4. Mukhamaagatya Mandala (hyperpigmented 
patch over face). 
Objective parameter 
Table1: Objective parameter size 
Size Score 
0-1 cm 1 
1-3 cm 2 
3-6 cm 3 
>6 cm 4 
Table 2: Objective parameter colour 
Colour Score 





Dark brown 6 
Standard graded scale (Fitzpatrick scale) is used to assess the change in colour of the skin in affected area 
before and after treatment. 
Assessment schedule 
Assessment of was done as per following schedule: 1st assessment- 1st day (before treatment) 
2nd assessment- 15th day (during treatment) 3rd assessment- 30th day (during treatment) 4th assessment- 60th 
day (after treatment) Likewise, data was collected of all the 30 patients. 
Assessment chart 
Table 3: Subjective Parameter 




After treatment (60 
days) 
1. Neerujam Yes/no Yes/no Yes/no 
2. Shyavam Yes/no Yes/no Yes/no 
3. Tanu Yes/no Yes/no Yes/no 
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Observation and Result 
Table 4: Objective Parameter 
Sl no Parameter Score 
  Before treatment Review after 30 days After treatment 60 Days 
1. Size 1.00-3.00 0.00-2.00 0.00-2.00 
2. Colour 2.00-6.00 1.00-5.00 1.00-5.00 
Result assessment: 
Finally over all result was calculated by taking average of all parameter results. 
Statistical methods 
Descriptive and inferential statistical analysis has been carried out in the present study. Results on continuous 
measurements are presented on Mean SD (Min-Max) and results on categorical measurements are presented in 
Number (%). Significance is assessed at 5 % level of significance. The following assumption on data is made. 
Observation and Results 
The study was conducted to evaluate the efficacy of Jatiphala choorna on Vyanga wsr to Melasma. A total of 30 
patients were selected randomly for the intended study. All the patients were assessed before and after 
treatment for the grading of their subjective and objective parameters. The observations and results are 
presented as follows. 
Study design: An observational clinical study.  
Table 5: Age distribution of patients studied 
Age in years No. of patients % 
<30 3 10.0 
30-40 10 33.3 
41-50 12 40.0 
51-60 5 16.7 
Total 30 100.0 
Mean ± SD: 41.67±8.69 
In the age wise distribution of the patients it was observed maximum of 12 (40%) were under the age 
group of 41-50 years, 10 ( 33.3%) were under the age group of 30-40 years, 5 (16.7%) were under the age 
group of 51-60 years and 3 (10%) were under the age group of 16-30 yrs. 
Table 6: Gender distribution of patients studied 
Gender No. of patients % 
Male 3 10.0 
Female 27 90.0 
Total 30 100.0 
In the present study among the 30 subjects, 27 (90%) were female and 3 (10%) were male. 
Table 7: Religion distribution in patients studied 
Religion No. of patients % 
Hindu 14 46.7 
Muslim 8 26.7 
Christian 8 26.7 
Total 30 100.0 
In the present study among 30 subjects, a maximum of 14 (46.7%) belong to Hindu religion, 8 (26.7%) 
belonged to Christian and 8 (26.7%) belonged to Muslim religion. 
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Table 8: Education distribution in patients studied 
Education No. of patients % 
Illiterate 7 23.3 
Elementary education 7 23.3 
Higher secondary 5 16.7 
Graduate 9 30.0 
Post graduate 2 6.7 
Total 30 100.0 
In the present study, it was observed that 7 subjects (23.3%) were Illiterate, 7 (23.3%) had elementary 
education, 5 (16.7%) had higher secondary education, 9 (30%) were graduates and 2 (6.7%) were post 
graduate. 
Table no 9: Marital Status distribution in patients studied 
Marital Status No. of patients % 
Unmarried 1 3.3 
Married 29 96.7 
Total 30 100.0 
In this study among 30 subjects, 29 (96.7%) were married and 1 (3.3%) were unmarried. 
Table no 10: Occupation distribution in patients studied 
Occupation No. of patients % 
Field work 2 6.7 
Office work 8 26.7 
House work 11 36.7 
Agriculture 5 16.7 
Student 1 3.3 
Teacher 3 10.0 
Total 30 100.0 
In the present study among 30 subjects 11 (36.7%) were House makers, 8 (26.7%) were Office Workers, 5 
(16.7%) were Agriculturist, 3 (10%) were Teachers, 2 (6.7%) were Field workers and 1 (3.3%) was a Student. 
Table 11: Habitat distribution in patients studied 
Habitat No. of patients % 
Urban 15 50.0 
Rural 15 50.0 
Total 30 100.0 
In the present study it was observed that maximum subjects i.e. 15 (50%) belong to Urban locality and 15 
(50%) were from Rural locality. 
Table no 12: Diet pattern distribution in patients studied 
Diet No. of patients % 
Veg 8 26.7 
Mixed 22 73.3 
Total 30 100.0 
In this study, 22 (73.3%) subjects were used to mixed diet and 8 (26.7%) subjects were vegetarians. 
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Table 13: Prakruthi distribution in patients studied 
Prakruthi No. of patients % 
Vataja pittaja 14 46.7 
Vata kaphaja 6 20.0 
Kapha pittaja 10 33.3 
Total 30 100.0 
In this study, 14 (46.7%) subjects are having Vata pittaja prakruthi, 10 (33.3%) are having Kapha pittaja 
prakruthi, and 6 (20%) are having Vata kaphaja prakruthi. 
Table 14: Onset of disease distribution in patients studied 
Onset No. of patients % 
Gradual 30 100.0 
Sudden 0 0.0 
Total 30 100.0 
In this study, the observation regarding the mode of onset of Vyanga in individual subjects in this study that 
majority of them 30 (100%) had gradual and 0% had insidious onset. 
Table 14: Previous Treatment distribution in patients studied 
Previous Treatment No. of patients % 
Fresh 25 83.3 
Treated 5 16.7 
Total 30 100.0 
In this study 25 subjects (83.3%) approached the hospital for the first time to take treatment and 5 (16.7%) 
had already taken different forms of treatment of different systems of varying duration. 
Effects on Treatment 
Objective Parameters 
Table 15: Size- An assessment at before and after treatment of patients studied 
Size Before 
Treatment 
30 days After Treatment % difference 
0-1cm 0 (0%) 3 (10%) 11 (36.7%) 36.7% 
1-3cm 4 (13.3%) 18 (60%) 16 (53.3%) 40.0% 
3-6cm 19 (63.3%) 9 (30%) 3 (10%) -53.3% 
>6cm 7 (23.3%) 0 (0%) 0 (0%) -23.3% 
Total 30 (100%) 30 (100%) 30 (100%) - 
Improvement of 76.7% up to 3 cm after treatment is significant with P<0.001**, paired proportion test 
Table 16: Colour - An assessment at before and after treatment of patients studied 
Colour Before 
Treatment 
30 days After 
Treatment 
% difference P value 
Very fair 0 (0%) 1 (3.3%) 4 (13.3%) 13.3% 0.020* 
Fair 1 (3.3%) 3 (10%) 4 (13.3%) 10.0% 0.088+ 
Medium 3 (10%) 6 (20%) 11 (36.7%) 26.7% 0.013* 
Olive 6 (20%) 9 (30%) 10 (33.3%) 13.3% 0.220 
Brown 9 (30%) 11 (36.7%) 1 (3.3%) -26.7% 0.004** 
Dark brown 11 (36.7%) 0 (0%) 0 (0%) -36.7% 0.0004** 
Total 30 (100%) 30 (100%) 30 (100%) -  
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Table 17: Size-An assessment at before and after treatment of patients studied 
Size Min-Max Mean ± SD difference t value P value 
Before Treatment 1.00-3.00 2.10±0.61 - - - 
30days 0.00-2.00 1.20±0.61 0.900 16.155 <0.001** 
After Treatment 0.00-2.00 0.73±0.64 1.367 12.173 <0.001** 
Table 18: Over All Assessment 
Parameter Mean BT Mean AT % of Improvement Remarks 
Size 2.10 0.73 65.2 Marked improvement 
Colour 4.87 3.00 38.30 Moderate improvement 
It was seen that trial drug worked better in improving the size of the lesion with 65.2% improvement (marked 
improvement) and showed 38.3% improvement i.e. moderate improvement in colour. 
DISCUSSION 
Discussion on selection on problem
Melasma or hyper pigmentation is the one 
among the top five leading conditions in Asia. 
Ethnicity, genetic factors, and sun exposure play 
important roles. The accurate prevalence of melasma 
world wide is unknown. This is attributed to the fact 
that melasma is a cosmetic problem and most 
patients may choose to consult their dermatologist 
privately. Hence, a low prevalence of melasma is 
recorded in most public dermatology clinics. 
Although melasma affects all races, it is most 
prevalent among darker skin phototypes and mainly 
found in patients of Hispanic, Latin Americans, 
Asians, Middle eastern and Africans descent. 
Melasma affects women more than men and 
occurs during child bearing age. Melasma occurs 10-
15% of pregnant women, 10-25% of women taking 
oral contraceptives. The major etiological factors 
include genetic influences, chronic sun exposure and 
female sex hormones. 
Ayurveda explains Vyanga as a disease which 
is mainly characterized by dark discolouration of the 
skin over face. It is a pathological situation of the 
facial skin which is produced due to the vitiation of 
Vata, Pitta, and Rakta producing cardinal features 
such as Niruja, Tanu, Shyava Mandala. 
Discussion on procedure 
Jatiphala seed was taken and it was pounded 
into small pieces using Khalva yantra and then it was 
put into pulveriser and powdered and it was packed 
into small zip lock airtight poly bags of about 30 gm 
each. Dose of the drug was not fixed depend on the 
area of the patches on the face. 
Probable mode of action 
The Katu Tikta Kashaya Rasa of Jatiphala 
tackles Srodusthi caused by Agnisada (which forms 
Ama and leads to Srotodusthi). The Tikta Rasa of 
Jatiphala causes Pitta Samaka which is vitiated due 
to intake of Pitta Ahara Dravyas. 
Since the disease Vyanga is considered the 
disease of disturbed Bhrajaka Pitta, Rasa, Rakta Vaha 
Sroto Dusti, Vata and Pitta Prakopa also involving 
Kapha which obstructs Rasavaha Srotas leading to 
Syavatwam of the skin by causing the Prakopita 
Bhrajaka Pitta to be deposited below the skin layers 
that is in epidermis. 
Tikta Rasa Usna Virya of Jatiphala mitigates 
Vata Dosa and the same time it stimulates Bhrajaka 
Pitta and help in scraping of the rough, thick, black 
dark layers formed on the skin. 
The Laghu Guna, Tikshna Guna and Ushna 
Virya properties along with Katu Rasa clears the 
channels helping the healthy Bhrajaka Pitta and 
opens the free movement of Bhrajaka Pitta on to the 
skin. Bhrajaka Pitta is responsible for Varna, Chayya, 
and Prabha. In Ashtanga Hridaya sutra sthana 12th 
chapter mentioned that Pitta located in the skin in 
Bhrajaka, because it helps exhibition of colour and 
complexion.  
Prabha and Chayya also effect on Varna. 
Acharya Charaka has written that Prabha is said to 
be highlighter of complexion. 
Myristicin present in Jatiphala is known to be 
useful in reducing the production of melanin 
secretion in skin. It also has antioxidant properties 
which act on free radicals. 
It was also observed that Jatiphala have got 
exfoliating property, which help in information of 
new fresh healthy skin removing unhealthy layer. 
Discussion on clinical study: 
 The clinical study was carried out on 30patients. 
 The type of skin lesion here in all subjects 
generally is Macule, as there is only discoloration, 
no pain, no discharge, no swelling. 
 Patients were asked to apply the Lepa triturated 
with water only, as it was clearly mentioned in 
Dipika commentary of Sharangadhara Samhita. 
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 Patients experienced slight burning sensation for 
about 5-10 minutes during the time of application 
of Lepa, this is due to the acidic nature of the Lepa. 
 There were no adverse effects or any other side 
effects like rashes, redness, itching etc observed 
during the time of application of Lepa. 
 Patients were asked not to get exposed to 
excessive sunlight during the one month of 
treatment as it leads to further Vata and Pitta 
Prakopa. 
 Thickness of Lepa should be Ardha Angula (which 
is approximately 0.88cm) as it is difficult to 
measure the thickness of the Lepa, patient was 
asked to apply the Lepa as thick as possible. 
 As seat of Vyangais in the 2nd layer of skin, that is 
Lohita according to Susrutha and Asrukdhara 
according to Charaka, the thickness of Lepa is such 
that it penetrates the second layer of the skin. 
Discussion on observations of clinical study 
The observations made in the present study 
were based on the clinical study conducted in a 
single group on 30 subjects. The data was collected 
in the proforma and analyzed after the completion of 
the study. 
Age 
In the present study among 30 subjects who 
completed the clinical trial, a maximum of 10 
(33.3%) were under the age of 30-40 years, 3 (10%) 
were under the age group 16-30 years and 12 
(40.0%) were under the age group of 41-50 years 
and 5 (16.7%) was under the age group of 51-60 
years. 
Hence, the inference can be drawn that the 
prevalence of Vyanga is more in middle aged people 
or Madhyama vayah. Vyanga is caused mainly due to 
Vata and Pitta Prakopa as Pitta Dosha is Prakupita in 
Madhyama Vayah, Vyanga is more prevalent in 
middle age. 
Gender 
In the present study among the 30 subjects, 
maximum of 27 (90%) were female and 3 (10%) 
were male. 
Among 27 female subjects, majority of them 
are workers and home makers having history of 
more sun exposure and stress/worry. Majority of 
them have acquired Vyanga post pregnancy, thus the 
prevalence in females may be attributed to post 
pregnancy sun exposure and stress/worry. 
Occupation 
In the present study, among 30 subjects 2 
(6.7%) were field workers, 11 (36.7%) were house 
makers, 1 (3.3%) were students and 3 (10%) were 
teachers, 8 (26.7%) was office work or businessman, 
5 (16.7 %) were agriculture. 
In all the above occupations people are 
exposed to sunlight and ultra violet rays. This 
attributes to the fact that Vyanga is prevalent more in 
the people who are more exposed to sunlight. 
Habitat 
In the present study, it was observed the 
maximum subjects i.e. 15 (50%) belong to urban 
locality and 15 (50%) were from rural locality. 
However no conclusion can be drawn, because of the 
small sample size. 
Deha prakruthi 
In the study, 14 (46.7%) subjects are having 
Vata Pittaja Prakruti, 10 (33.3%) subjects, are having 
Kapha Pittaja Prakruthi, 6 (20%) subjects are having 
Vata Kaphaja Prakruti. 
This attributes to the fact that Vyanga is more 
seen in people with Vata Pittaja Prakruti. 
Fresh/Treated 
In this study, 25 subjects (83.3%) 
approached the hospital for the first time to take 
treatment and 5 (16.7%) had already taken different 
forms of treatment of different systems of varying 
duration. 
This indicates recurrent/episodic nature of 
the disease and lack of permanent treatment for 
Vyanga in other systems of medicine which requires 
early management. 
Family history of Vyanga 
In the present study among 30 subjects, 
family history of Vyanga with special reference to 
hyper pigmentation on face was totally absent, which 
is shows that there is no involvement of genetic 
factors. 
Religion, Educational Status, Diet 
No significant relationship can be drawn in 
the above parameters in relation to Vyanga with 
special reference to hyper pigmentation on face. 
Discussion on results of clinical study 
In the present study the results of subjective 
parameters which were assessed such as colour of 
the patch area and size of the patch area showed 
statistically highly significant reduction with the p 
value less than 0.05. 
This can be attributed chiefly to the Varnya, 
Vatapitta Shamaka, Kapha Pitta Shamaka, Sheeta 
Veerya, Katu Vipaka, cooling, disinfectant and blood 
purifying anti-inflammatory properties of the drugs 
present in the intervention, decreases about Vata 
and Pitta in the Twacha and enhances Varna of 
Twacha. Therefore the pathological disintegration – 
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Niruja, Shyava, Tanu, Mukhamandala i.e. size and 
colour of the patch area gets decreased. 
The decreased in the mean suggests 
significant reduction in the Vyanga. It also indicates 
that after each day of intervention the severity of the 
condition is getting relieved, which can be attributed 
to the Varnya, Vata Pitta Shamaka, Kapha Pitta 
Shamaka, Sheeta Veerya, Katu Vipaka, cooling, 
disinfectant and blood purifying anti-inflammatory 
properties of the drugs present in the intervention. 
Hence, it was inferred that the intervention 
selected for the present study has shown combined 
effect in the management of Vyanga vis-a-vis hyper 
pigmentation on face. 
CONCLUSION 
On the basis of reviews collected, analysis of 
analytical study, results and observations on the 
clinical study, the following conclusions may be 
drawn. 
Acharya Bhavamishra clearly mentioned 
Jatiphala as a single herbal remedy for its action on 
Vyanga. The Katu, Tikta Rasa of Jatiphala removes 
Srodusti thereby helping free movement of healthy 
Bhrajaka Pitta to the skin. Tikta Rasa and Usna Virya 
of Jatiphala prevent Vata Dosha thereby reducing 
Kharatwa and Krishnatwa of skin. 
The Snigdha, Soumya, Sita, and Twak 
Prasadana properties along with Rasayana property 
help in reducing Vyanga and skin in more permeable 
to lipids than aqueous solution. The Lepa procedure 
helps in micro absorption and improves micro 
circulation of chemical constituents of drugs due to 
the disintegration of drug particles into the finest 
form. 
The chemical compound ‘Myristicin’ present 
in it may help to reduce the production of melanin in 
skin. 
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